This announcement is a separate document:
中源协和细胞基因工程股份有限公司董事会审计委员会2023年度履职情况报告
Report on the performance of the Audit Committee of the Board of Directors of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. 2023
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.